2013
DOI: 10.1007/s12032-012-0396-4
|View full text |Cite
|
Sign up to set email alerts
|

Effects of EHD2 interference on migration of esophageal squamous cell carcinoma

Abstract: C-Terminal EH domain-containing protein 2 (EHD2) of the EHD family is associated with plasma membrane. We investigated the expression of EHD2 in human esophageal squamous cell carcinoma (ESCC) and the EHD2 expression to study the therapeutic effect of chemotherapy drugs. Western blot and immunohistochemistry were used to measure the expression of EHD2 protein in ESCC and adjacent normal tissue in 98 patients. EHD2 protein level was reduced in ESCC tissues in comparison with adjacent normal tissues. Under-expre… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

1
30
0

Year Published

2013
2013
2024
2024

Publication Types

Select...
9

Relationship

2
7

Authors

Journals

citations
Cited by 33 publications
(31 citation statements)
references
References 22 publications
(21 reference statements)
1
30
0
Order By: Relevance
“…Cell motility and invasion are essential features of the metastatic process (Li et al 2013a). Identifying the molecules and pathways that control cell motility and invasion is critical to understanding cancer metastasis.…”
Section: Discussionmentioning
confidence: 99%
“…Cell motility and invasion are essential features of the metastatic process (Li et al 2013a). Identifying the molecules and pathways that control cell motility and invasion is critical to understanding cancer metastasis.…”
Section: Discussionmentioning
confidence: 99%
“…Under-expression of EHD2 increased the motility property of ESCC cell TE1 in vitro. [141] Under-expression of EHD2 has also been reported in malignant serous ovarian cancer samples. [142] A new mechanical role for caveolae in cancer?…”
Section: Caveolae New Partners and Cancermentioning
confidence: 96%
“…Tissues with no staining were rated as 0, with a faint staining or moderate to strong staining in ≤25% of cells as 1, with a moderate staining in 25-50% of cells as 2, with strong staining ≥50% of cells as 3. For statistical analysis, <2 was regarded as low expression and ≥2 as overexpression [20].…”
Section: Immunohistochemistry (Ihc)mentioning
confidence: 99%
“…In this study, we detected the expression of AGS3 in ESCC patients and the potential functional relationship in tumor proliferation and prognosis. To examine the potential tumor-suppressive activity of AGS3in ESCC, AGS3 was transfected into a common ESCC cell line, TE1 [20]. Overexpression of AGS3 caused the proliferation of esophageal squamous cells TE1 to decrease significantly.…”
Section: Introductionmentioning
confidence: 99%